Carmichael Hill & Associates, Inc. Beyond Air, Inc. Transaction History
Carmichael Hill & Associates, Inc.
- $253 Million
- Q2 2024
A detailed history of Carmichael Hill & Associates, Inc. transactions in Beyond Air, Inc. stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 8,000 shares of XAIR stock, worth $3,040. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000
Previous 8,000
-0.0%
Holding current value
$3,040
Previous $13,000
69.23%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding XAIR
# of Institutions
68Shares Held
11.2MCall Options Held
54.4KPut Options Held
7K-
Aigh Capital Management LLC Baltimore, MD3.64MShares$1.38 Million0.71% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.36MShares$516,1020.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$480,5150.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX1.23MShares$465,6020.12% of portfolio
-
Black Rock Inc. New York, NY519KShares$197,2140.0% of portfolio
About Beyond Air, Inc.
- Ticker XAIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,888,000
- Market Cap $11.4M
- Description
- Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...